HSP90AA1 and cancer: Although much of the original rationale that made Hsp90 a promising drug target was directed at Hsp90α′s role in aiding cancer progression, Hsp90α and Hsp90β share a significant overlap of client proteins, which appear to serve an intrinsic redundancy.